EVOFOSFAMIDE: 33 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
33
Total FAERS Reports
12 (36.4%)
Deaths Reported
14
Hospitalizations
33
As Primary/Secondary Suspect
First Report: 20120811 · Latest Report: 20171220
What Are the Most Common EVOFOSFAMIDE Side Effects?
#1 Most Reported
Fatigue
7 reports (21.2%)
#2 Most Reported
Sepsis
6 reports (18.2%)
#3 Most Reported
Neutropenia
6 reports (18.2%)
All EVOFOSFAMIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 7 | 21.2% | 2 | 2 |
| Neutropenia | 6 | 18.2% | 2 | 1 |
| Sepsis | 6 | 18.2% | 6 | 0 |
| Pneumonia | 5 | 15.2% | 2 | 3 |
| Product use issue | 5 | 15.2% | 0 | 0 |
| Thrombocytopenia | 5 | 15.2% | 2 | 0 |
Who Reports EVOFOSFAMIDE Side Effects? Age & Gender Data
Gender: 54.2% female, 45.8% male. Average age: 59.5 years. Most reports from: US. View detailed demographics →
Is EVOFOSFAMIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 3 | 0 | 3 |
| 2013 | 3 | 1 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 1 |
What Is EVOFOSFAMIDE Used For?
| Indication | Reports |
|---|---|
| Sarcoma | 8 |
| Sarcoma metastatic | 6 |
Official FDA Label for EVOFOSFAMIDE
Official prescribing information from the FDA-approved drug label.